chemotherapy for breast cancer after surgery

Ngày tải lên: 09/08/2014, 09:20

... (preoperative and postoperative) chemotherapy for locally advanced gastric cancer [3]. Up to this point, many neoadjuvant chemotherapy treatments for gastric cancer have been used with varying ... requiring relaparotomies after 700 gastretomies performed for gastric cancer. Am J Surg 1996; 171(2): 270-3. 10. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br ... neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg 2003; 7(8): 1015-22; discussion 1023. 18. Viste A, Haùgstvedt T, Eide GE, Søreide O. Postoperative complications and mortality after surgery...

Ngày tải lên: 09/08/2014, 02:21

... individual risks for breast cancer 60-85% and may be identified in 5-10% of all breast cancer cases. 28 Personal history of noninvasive breast cancer or previous abnormal breast biopsy containing ... Breast cancer is the most frequently diagnosed non-cutaneous cancer and the second leading cause of cancer deaths after lung cancer among women in the United States. 7 In 2008, an Breast Cancer ... group (7% for invasive cancer) 15 years after discontinuing screening. 106 Breast Cancer Screening Oregon Evidence-based Practice Center 21 acceptable surgical treatment for breast cancer. 46 ...

Ngày tải lên: 14/02/2014, 21:20

... background for our information in this leaflet below. SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY What are the benefits and harms of attending a screening programme for breast cancer? ... 1000 get breast cancer and die from it. The absolute reduction in breast cancer mortality was therefore only 0.1% (1 out of 1000) after 10 years in the Swedish trials. Screening for more than ... treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ 2011;343:d4692. 20. NHS cancer screening programmes. BASO Breast Audit 1999/2000. www.cancerscreening.nhs.uk/breastscreen/publications.html...

Ngày tải lên: 15/02/2014, 05:20

... nanocapsule form. This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breast cancer cell ... characterized for particle size, zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the SUM 225 breast cancer cell line by dynamic light scattering, high performance ... acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapy Nanoscale...

Ngày tải lên: 18/06/2014, 22:20

... in human breast cancer cells and therefore have considerable potential for treatment of breast cancer. Keywords Nanoparticles Á MDR Á Pluronic F68 Á Poly (e-caprolactone) Á Docetaxel Á Breast cancer Introduction Cancer ... multidrug resistance in human breast cancer cells and therefore have considerable potential for treatment of breast cancer. Acknowledgments The authors are grateful for financial support from the ... IC 50 value for MCF-7 TAX30 cells was decreased from 10.380, 8.726, and 5.945 lg/mL for Taxotere Ò to 7.388, 3.643, and 1.244 lg/mL for PCL NP formulation and to 1.019, 0.384, and 0.196 lg/mL for PCL/Pluronic...

Ngày tải lên: 22/06/2014, 00:20

... treatment is therefore not as effective as it should be. Mortality due to breast cancer is decreasing in most western countries, because of mass screening, frequent use of post-operative chemotherapy ... understood breast cancer heterogeneity better. Two recent papers in Genome Biology from the laboratories of Carlos Caldas [1] and Eric Miska [2] use molecular methods to classify breast cancers ... hheetteerrooggeenneeiittyy Because breast cancer heterogeneity arises from many different factors, several directions of research must be pursued simultaneously if we are to understand and cope with the different forms of breast...

Ngày tải lên: 06/08/2014, 18:21

... Nelson BK: Seroma formation following breast cancer surgery. Breast J 2003, 5:385-8. 10. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL: Seroma formation after breast cancer surgery: incidence ... suction drainage for the axillary wound after lymphadenectomy for breast cancer. Br J Surg 2006, 93:820-4. 32. Gong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, Xiong B: Prevention of seroma formation after ... of seromas following breast cancer surgeries: seromas following breast cancer surgeries. Breast J 2007, 13:588-92. 21. Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formation following...

Ngày tải lên: 09/08/2014, 02:20

... localized estrogen receptors in human breast cancer. Cancer Res 1990, 5012:3545-3550. 9. British Breast Group: Assessment of response to treatment in advanced breast cancer. Lancet 1974, 2:38-39. 10. ... receptor positive, operable primary breast cancer in elderly (age > 70 years), locally advanced or metastatic breast cancer; (2) disease deemed suitable for treatment by hormonal manipulation; ... therapy. Methods Case-notes of the breast cancer patients treated in the Nottingham breast unit since 1998 fulfilling the follow- ing criteria were studied retrospectively: ã ER positive invasive breast carcinoma...

Ngày tải lên: 09/08/2014, 02:21

Ngày tải lên: 09/08/2014, 03:22

Ngày tải lên: 09/08/2014, 04:21

Ngày tải lên: 09/08/2014, 09:20

Ngày tải lên: 11/08/2014, 00:23

Ngày tải lên: 11/08/2014, 05:22

Ngày tải lên: 11/08/2014, 16:20

... Table 2. Significant predictive factors for PFS duration after a first line chemotherapy. Table 3 . Predictive factors for OS duration after a first line chemotherapy. Int. J. Med. Sci. ... patients treated for metastatic breast cancer in 4 French cancer centres. The diagnosis of metastasis was made between 1992 and 2002. A total of 772 patients received first-line chemotherapy ... first-line chemotherapy in this study seems to indicate that this strategy should be recommended in patients with an ER or PgR positive tumour. Key words: Breast cancer; maintenance treatment; chemotherapy; ...

Ngày tải lên: 08/08/2014, 17:20